Benchmark Reiterates Buy on Biofrontera, Maintains $7 Price Target

Biofrontera Inc. -0.99%

Biofrontera Inc.

BFRI

1.00

-0.99%

Benchmark analyst Bruce Jackson reiterates Biofrontera (NASDAQ: BFRI) with a Buy and maintains $7 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via